Caroline is an Investment Analyst at Hatteras, where she manages the firm's deal flow process, conducts company diligence, and supports a range of strategic initiatives.
Caroline earned a Ph.D. in Molecular Cancer Biology from Duke University, where her research focused on identifying novel drug targets for metastatic lung cancer and was supported by the Ruth L. Kirschstein National Research Service Award. While at Duke, she also earned a Certificate in Innovation and Entrepreneurship from the Fuqua School of Business and served as a Senior Fellow in the Office of Translation and Commercialization, where she evaluated various technologies developed at Duke for their commercial potential.
Prior to Duke, Caroline spent three years as a researcher at Fred Hutchinson Cancer Center and worked at a seed-stage biotech venture based in Seattle. She holds a B.S. in Microbiology from the University of Washington.
.